Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-30

Clinical Trial Update: Aripiprazole in Children With Autism: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated aripiprazole in children with autism; the study status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Autism | Phase 2 | Status: COMPLETED